Athira Pharma Investors Win OK Of $10M Deal On Second Try

By Gina Kim · February 16, 2024, 9:42 PM EST

Over 30,000 Athira Pharma investors have scored preliminary approval of a $10 million settlement over claims its former CEO manipulated studies relating to an Alzheimer's drug, five months after a Washington...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Nacif et al v. Athira Pharma Inc et al

Case Number

2:21-cv-00861

Court

Washington Western

Nature of Suit

Securities/Commodities

Date Filed

June 25, 2021